期刊文献+

血栓调节蛋白基因多态性与冠心病相关性的Meta分析 被引量:3

A Meta-analysis on correlation between genetic polymorphism of thrombomodulin and coronary heart disease
下载PDF
导出
摘要 目的评价血栓调节蛋白(TM)基因G-33A和C1418T多态性与冠心病(CHD)的相关性。方法检索Cochrance图书馆、PubMed数据库、中国生物医学文献数据库(CBM)、万方数据库和中国学术期刊全文数据库(CNKI),检索日期为1987年1月1日至2013年4月30日,收集血栓调节蛋白基因多态性与冠心病相关性的病例对照研究和队列研究,按照纳入和排除标准选择提取数据资料并评价,采用RevMan5.2.3软件进行Meta分析。结果共纳入14篇文献(病例组3039例,对照组5480例)。Meta分析显示,亚洲人TM基因G-33A多态性和CHD之间存在相关性(G vs.A,P=0.002;GG vs.GA,P=0.002;GG vs.GA+AA,P=0.0002),而C1418T多态性和CHD之间不存在相关性(P>0.05)。结论亚洲人TM基因G-33A多态性与CHD之间存在相关性,而C1418T多态性和CHD之间不存在相关性。 Objective To review the correlation between genetic polymorphism of thrombomodulin (TM) and coronary heart disease (CHD). Methods The databases of Cochrance Library, PubMed, CBM, WanFang Database and CNKI were retrieved from Jan. 1, 1987 to Apr. 30, 2013 for collecting case-control studies and cohort studies on the correlation between genetic polymorphism of TM and CHD. The data was extracted according to the inclusion and exclusion criteria and reviewed, and then given a Meta-analysis by using RevMan5.2.3 software. Results There were totally 14 studies included involving 3039 cases in case group and 5480 in control group. The Meta-analysis showed that there was correlation between genetic polymorphism of TM G-33A and CHD (G vs. A, P=0.002;GG vs. GA, P=0.002;GG vs. GA+AA, P=0.0002) in Asian population, while there was no correlation between genetic polymorphism of C1418T and CHD (P〈0.05). Conclusion The genetic polymorphism of TM G-33A is correlated and C1418T is not to CHD.
出处 《中国循证心血管医学杂志》 2014年第1期15-19,共5页 Chinese Journal of Evidence-Based Cardiovascular Medicine
关键词 血栓调节蛋白 基因多态性 冠状动脉粥样硬化性心脏病 META分析 Thrombomodulin Genetic polymorphism Coronary heart disease Meta-analysis
  • 相关文献

参考文献29

  • 1Talmud PJ. Gene-environment interaction and its impact on coronary heart disease risk [J]. Nutr Metab Cardiovasc Dis,2007,17(2):148-52.
  • 2Conway EM. Thrombomodulin and its role in inflammation[J]. Semin Immunopathol,2012,34(1): 107-25.
  • 3Carnemolla R,Patel KR,Zaitsev S,et al. Quantitative analysis of conversion of protein C to APC: translation from in vitro to in vivo [J]. J Immunol Methods,2012,384(1-2):21-4.
  • 4曾宪涛,刘慧,陈曦,冷卫东.Meta分析系列之四:观察性研究的质量评价工具[J].中国循证心血管医学杂志,2012,4(4):297-299. 被引量:974
  • 5Norlund L,Holm J,Zoller B,et al. A common thromhomodulin amino acid dimorphism is associated with myocardial infarction [J]. Thromb Haemost, 1997,77(2):248-51.
  • 6Li YH,Chen JH,Wu HL,et al. G-33A mutation in the promoter region of thrombomodulin gene and its association with coronary artery disease and plasma soluble thrombomodulin levels[J]. Am J Cardiol,2000,85(1):8-12.
  • 7Wu KK,Aleksic N,Ahn C,et al. Thrombomodulin Ala455Val polymorphism and risk of coronary heart diase[J]. Circulation,2001,103 (10):1386-9.
  • 8Li YH,Chen JH,Tsai WC,et al. Synergistic effect of thrombomodulin promoter -33G/A polymorphism and smoking on the onset of acute myocardial infarction [J]. Thromb Haemost,2002,87(1):86-91.
  • 9Park HY,Nabika T,Jang Y,et al. Association of G-33A polymorphism in the thrombomodulin gene with myocardial infarction in Koreans [J]. Hypertens Res,2002,25(3):389-94.
  • 10Ranjith N,Pegoraro RJ,Rom L. Haemostatic gene polymorphisms in young indian asian subjects with acute myocardial infarction [J]. Med Sci Monit,2003, 9(10):CR417-21.

二级参考文献33

  • 1Le Flem L, Picard V, Emmerich J, et al. Mutations in promoter region of thrombomodulin and venous thromboembolic disease [ J ]. Arterioscler Thromb Vasc Biol, 1999, 19 (4): 1098-1104.
  • 2Li YH, Chen JH, Tsal WC, et al. Synergistic effect of thrombomodulin promoter-33G/A polymorphism and smoking on the onset of acute myocardial infarction [J]. Thromb Haemost, 2002 , 87 (1): 86-91.
  • 3Li YH, Chen CH, Yeh PS, et al. Functional mutation in the promoter region of thrombomodulin gene in relation to carotid atherosclerosis [J]. Atherosclerosis, 2001, 154 (3): 713-719.
  • 4Conway EM, Van De Wouwer M, domain ofthrombomodulin confers Pollefeyt S, et al. The Lectin-like protection from neutrophil-mediated tissue damage by suppressing adhesion molecule expression via nuclear factor kappaB and mitogen-activated protein kinase pathways [ J]. J Exp Med, 2002, 196 (5): 565-577.
  • 5Stearns-Kurosawa DJ, Kurosawa S. The endothelial cell protein C receptor augment protein C activation by the thrombin/thrombomodulin complex[J]. Proc Natl Acad Sci USA, 1996, 93 (19): 10212- 10216.
  • 6Yi-Heng L, Jyh-Hong C. Fuctional significance of G-33A promoter mutation of thrombomodulin gene and its influence on plasma soluble thrombomodulinlevel in patients with coronary artery disease [J]. J Am Coll Cardiol, 2000, 35: 259A.
  • 7Park HY, Nabika T, Jang Y, et al. Association of G-33A polymorphism in the thrombomodulin gene with myocardial infarction in Koreans [J]. Hypertens Res, 2002, 25 (3): 389-394.
  • 8Chao TH, Li YH, Chen JH et al, Relation of thrombomodulin gene polymorphisms to acute myocardial infarction in patients < or = 50 years of age [J]. Am J Cardiol. 2004, 93 (2) : 204-207.
  • 9Salomaa V, Matei C, Aleksic N, et al, Soluble thrombomodulin as a predictor of incident coronary heart disease and symptomless carotid artery atherosclerosis in the Atherosclerosis Risk in Communities (ARIC) Study: a case-cohort study [J]. Lancet, 1999, 353 (9166): 1729-1734.
  • 10Tazawa R, Hirosawa S, Suzuki K, et al. Functional characterization of the 5' -regulatory region of the human thrombomodulin gene [ J ]. J Biochem, 1993, 113 (5): 600-606.

共引文献979

同被引文献61

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部